Standout Papers
Immediate Impact
55 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Hao Xing being referenced
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma
2020
Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Hao Xing | 192 | 499 | 201 | 281 | 256 | 28 | 909 | |
| Hanako Tsujikawa | 239 | 434 | 136 | 309 | 398 | 36 | 1.1k | |
| Li‐Jian Liang | 129 | 528 | 244 | 288 | 462 | 33 | 961 | |
| Hong Wang | 140 | 570 | 236 | 299 | 164 | 29 | 820 | |
| Yefa Yang | 144 | 346 | 136 | 139 | 243 | 39 | 797 | |
| Wen‐Feng Gong | 149 | 775 | 272 | 426 | 311 | 28 | 1.1k | |
| Anna Kan | 166 | 333 | 147 | 160 | 260 | 37 | 863 | |
| Yusuke Mitsunori | 217 | 245 | 178 | 218 | 425 | 40 | 988 | |
| Qiankun Xie | 196 | 369 | 266 | 178 | 464 | 31 | 1.0k | |
| Joerg Trojan | 163 | 313 | 205 | 138 | 306 | 30 | 914 | |
| Yoshio Katamura | 185 | 507 | 252 | 331 | 170 | 32 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...